{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:23:11Z","timestamp":1794504191776,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["STaR Award"],"award-info":[{"award-number":["STaR Award"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["OF LCG 000207"],"award-info":[{"award-number":["OF LCG 000207"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["and a clinical translational research programme in Parkinson\u2019s disease"],"award-info":[{"award-number":["and a clinical translational research programme in Parkinson\u2019s disease"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council,Singapore","doi-asserted-by":"crossref","award":["CS-IRG"],"award-info":[{"award-number":["CS-IRG"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council,Singapore","doi-asserted-by":"crossref","award":["OF-IRG"],"award-info":[{"award-number":["OF-IRG"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Singhealth-Duke-NUS","award":["Singhealth-Duke-NUS AM position grant"],"award-info":[{"award-number":["Singhealth-Duke-NUS AM position grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04660-4","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:15:37Z","timestamp":1758806137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Three-dimensional midbrain organoids: a next-generation tool for Parkinson\u2019s disease modelling and drug discovery"],"prefix":"10.1186","volume":"16","author":[{"given":"Rosalie","family":"Elvira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"4660_CR1","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T. Projections for prevalence of parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021. BMJ. 2025;388:e080952.","journal-title":"BMJ"},{"key":"4660_CR2","unstructured":"Boiles A. Parkinson\u2019s disease economic burden on patients, families and the federal government is $52 billion, doubling previous estimates. 2025. https:\/\/www.michaeljfox.org\/publication\/parkinsons-disease-economic-burden-patients-families-and-federal-government-52-billion."},{"key":"4660_CR3","unstructured":"Butters J. The social impact of Parkinson\u2019s. https:\/\/www.bu.edu\/articles\/2015\/social-impact-parkinsons-disease\/."},{"issue":"1","key":"4660_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade RM, Fairlie DP, Mason JM. Alpha-synuclein structure and parkinson\u2019s disease \u2013 lessons and emerging principles. Mol Neurodegeneration. 2019;14(1):29.","journal-title":"Mol Neurodegeneration"},{"key":"4660_CR5","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects [Internet]","author":"A Kouli","year":"2018","unstructured":"Kouli A, Kuan TK. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, G. J., editor. Parkinson\u2019s disease: pathogenesis and clinical aspects [Internet]. Codon Publications: Brisbane (AU); 2018."},{"key":"4660_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2023.06.026","volume":"360","author":"EF van Vliet","year":"2023","unstructured":"van Vliet EF, Knol MJ, Schiffelers RM, Caiazzo M, Fens MHAM. Levodopa-loaded nanoparticles for the treatment of parkinson\u2019s disease. J Controlled Release. 2023;360:212\u201324.","journal-title":"J Controlled Release"},{"key":"4660_CR7","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"I Zahoor","year":"2018","unstructured":"Zahoor I, Haq SA. Pharmacological treatment of parkinson\u2019s disease. In: Stoker TB, G. J., editor. Parkinson\u2019s disease: pathogenesis and clinical aspects. Ed. Codon Publications: Brisbane (AU); 2018."},{"key":"4660_CR8","doi-asserted-by":"crossref","unstructured":"Schuepbach WMM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, H\u00e4lbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Malt\u00eate D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Kr\u00fcger R, Pinsker MO, Amtage F, R\u00e9gis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G. Neurostimulation for Parkinson\u2019s disease with early motor complications. New Engl J Med. 2013;368(7):610\u201322.","DOI":"10.1056\/NEJMoa1205158"},{"issue":"02","key":"4660_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0037-1602423","volume":"37","author":"ME Freitas","year":"2017","unstructured":"Freitas ME, Hess CW, Fox SH. Motor complications of dopaminergic medications in parkinson\u2019s disease. Semin Neurol. 2017;37(02):147\u201357.","journal-title":"Semin Neurol"},{"issue":"3","key":"4660_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ymthe.2021.01.001","volume":"29","author":"G MacDougall","year":"2021","unstructured":"MacDougall G, Brown LY, Kantor B, Chiba-Falek O. The path to progress preclinical studies of Age-Related neurodegenerative diseases: A perspective on rodent and hiPSC-Derived models. Mol Ther. 2021;29(3):949\u201372.","journal-title":"Mol Ther"},{"issue":"1","key":"4660_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-025-00837-w","volume":"20","author":"SL Boschen","year":"2025","unstructured":"Boschen SL, Mukerjee A, Faroqi A;H, Rabichow A;E, Fryer B. Research models to study lewy body dementia. Mol Neurodegeneration. 2025;20(1):46.","journal-title":"Mol Neurodegeneration"},{"key":"4660_CR12","unstructured":"FDA. FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs [Press release], vol. 2025; 2025. p. 29."},{"issue":"4","key":"4660_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"8","key":"4660_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","volume":"45","author":"A Bose","year":"2022","unstructured":"Bose A, Petsko GA, Studer L. Induced pluripotent stem cells: a tool for modeling parkinson\u2019s disease. Trends Neurosci. 2022;45(8):608\u201320.","journal-title":"Trends Neurosci"},{"issue":"5","key":"4660_CR15","doi-asserted-by":"publisher","first-page":"20220040","DOI":"10.1098\/rsfs.2022.0040","volume":"12","author":"A Bhargava","year":"2022","unstructured":"Bhargava A, Sandoval Castellanos AM, Shah S, Ning K. An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders. Interface Focus. 2022;12(5):20220040.","journal-title":"Interface Focus"},{"key":"4660_CR16","doi-asserted-by":"publisher","first-page":"122610","DOI":"10.1016\/j.lfs.2024.122610","volume":"345","author":"HWS Babu","year":"2024","unstructured":"Babu HWS, Kumar SM, Kaur H, Iyer M, Vellingiri B. Midbrain organoids for parkinson\u2019s disease (PD) - A powerful tool to understand the disease pathogenesis. Life Sci. 2024;345:122610.","journal-title":"Life Sci"},{"issue":"1","key":"4660_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41531-024-00799-8","volume":"10","author":"X Cui","year":"2024","unstructured":"Cui X, Li X, Zheng H, Su Y, Zhang S, Li M, Hao X, Zhang S, Hu Z, Xia Z, Shi C, Xu Y, Mao C. Human midbrain organoids: a powerful tool for advanced parkinson\u2019s disease modeling and therapy exploration. Npj Parkinson\u2019s Disease. 2024;10(1):189.","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"7378","key":"4660_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim J-W, Piao J, Ganat YM, Wakeman DR, Xie Z, Carrillo-Reid L, Auyeung G, Antonacci C, Buch A, Yang L, Beal MF, Surmeier DJ, Kordower JH, Tabar V, Studer L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of parkinson\u2019s disease. Nature. 2011;480(7378):547\u201351.","journal-title":"Nature"},{"issue":"1","key":"4660_CR19","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1038\/s41598-017-05633-1","volume":"7","author":"S Fedele","year":"2017","unstructured":"Fedele S, Collo G, Behr K, Bischofberger J, M\u00fcller S, Kunath T, Christensen K, G\u00fcndner AL, Graf M, Jagasia R, Taylor V. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential. Sci Rep. 2017;7(1):6036.","journal-title":"Sci Rep"},{"issue":"1","key":"4660_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00441-004-0916-4","volume":"318","author":"E Roussa","year":"2004","unstructured":"Roussa E, Krieglstein K. Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-\u03b2. Cell Tissue Res. 2004;318(1):23\u201333.","journal-title":"Cell Tissue Res"},{"key":"4660_CR21","doi-asserted-by":"crossref","unstructured":"Yeap YJ, Teddy TJW, Lee MJ, Goh M, Lim KL. From 2D to 3D: development of monolayer dopaminergic neuronal and midbrain organoid cultures for parkinson\u2019s disease modeling and regenerative therapy. In Int J Mol Sci, 2023; 24.","DOI":"10.3390\/ijms24032523"},{"issue":"2","key":"4660_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo J, Xiao Y, Sun AX, Cukuroglu E, Tran H-D, G\u00f6ke J, Tan ZY, Saw TY, Tan C-P, Lokman H, Lee Y, Kim D, Ko HS, Kim S-O, Park JH, Cho N-J, Hyde TM, Kleinman JE, Shin JH, Weinberger DR, Tan EK, Je HS, Ng H-H. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and Neuromelanin-Producing neurons. Cell Stem Cell. 2016;19(2):248\u201357.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4660_CR23","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1038\/s41467-021-27464-5","volume":"12","author":"A Fiorenzano","year":"2021","unstructured":"Fiorenzano A, Sozzi E, Birtele M, Kajtez J, Giacomoni J, Nilsson F, Bruzelius A, Sharma Y, Zhang Y, Mattsson B, Emn\u00e9us J, Ottosson DR, Storm P, Parmar M. Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids. Nat Commun. 2021;12(1):7302.","journal-title":"Nat Commun"},{"issue":"2","key":"4660_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen MMA, Coppes RP, Beghin A, De Coppi P, Gerli MFM, de Graeff N, Pan Q, Saito Y, Shi S, Zadpoor AA, van der Laan LJ. W., clinical applications of human organoids. Nat Med. 2025;31(2):409\u201321.","journal-title":"Nat Med"},{"key":"4660_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4252\/wjsc.v11.i9.634","volume":"11","author":"M Ke","year":"2019","unstructured":"Ke M, Su CC. Using induced pluripotent stem cells for modeling parkinson\u2019s disease. World J Stem Cells. 2019;11:634\u201349.","journal-title":"World J Stem Cells"},{"issue":"5","key":"4660_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer D, Jaenisch R. Induced pluripotent stem cells Meet genome editing. Cell Stem Cell. 2016;18(5):573\u201386.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"4660_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","volume":"12","author":"H Kim","year":"2019","unstructured":"Kim H, Park HJ, Choi H, Chang Y, Park H, Shin J, Kim J, Lengner CJ, Lee YK, Kim J. Modeling G2019S-LRRK2 sporadic parkinson\u2019s disease in 3D midbrain organoids. Stem Cell Rep. 2019;12(3):518\u201331.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"4660_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.26166","volume":"90","author":"J Jo","year":"2021","unstructured":"Jo J, Yang L, Tran H-D, Yu W, Sun AX, Chang YY, Jung BC, Lee S-J, Saw TY, Xiao B, Khoo ATT, Yaw L-P, Xie JJ, Lokman H, Ong W-Y, Lim GGY, Lim K-L, Tan E-K, Ng H-H, Je HS. Lewy Body\u2013like inclusions in human midbrain organoids carrying glucocerebrosidase and \u03b1-Synuclein mutations. Ann Neurol. 2021;90(3):490\u2013505.","journal-title":"Ann Neurol"},{"issue":"8","key":"4660_CR29","doi-asserted-by":"publisher","first-page":"eabb1540","DOI":"10.1126\/sciadv.abb1540","volume":"7","author":"N Wulansari","year":"2021","unstructured":"Wulansari N, Darsono WHW, Woo H-J, Chang M-Y, Kim J, Bae E-J, Sun W, Lee J-H, Cho I-J, Shin H, Lee S-J, Lee S-H. Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying parkinson\u2019s disease-linked DNAJC6 mutations. Sci Adv. 2021;7(8):eabb1540.","journal-title":"Sci Adv"},{"issue":"7","key":"4660_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","volume":"30","author":"MS Kim","year":"2023","unstructured":"Kim MS, Ra EA, Kweon SH, Seo BA, Ko HS, Oh Y, Lee G. Advanced human iPSC-based preclinical model for parkinson\u2019s disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell. 2023;30(7):973\u2013e98611.","journal-title":"Cell Stem Cell"},{"key":"4660_CR31","doi-asserted-by":"crossref","unstructured":"Renner H, Becker KJ, Kagermeier TE, Grabos M, Eliat F, G\u00fcnther P, Sch\u00f6ler HR, Bruder JM. Cell-Type-Specific high throughput toxicity testing in human midbrain organoids. Front Mol Neurosci 2021, Volume 14\u20132021.","DOI":"10.3389\/fnmol.2021.715054"},{"issue":"7","key":"4660_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1021\/acssensors.4c00476","volume":"9","author":"J An","year":"2024","unstructured":"An J, Shin M, Beak G, Yoon J, Kim S, Cho H-Y, Choi J-W. Drug evaluation of parkinson\u2019s disease Patient-Derived midbrain organoids using mesoporous Au Nanodot-Patterned 3D concave electrode. ACS Sens. 2024;9(7):3573\u201380.","journal-title":"ACS Sens"},{"issue":"8064","key":"4660_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","volume":"641","author":"V Tabar","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH, Brennan C, Ma Y, Peng S, Eidelberg D, Tomishima M, Irion S, Stemple W, Abid N, Lampron A, Studer L, Henchcliffe C. Phase I trial of hES cell-derived dopaminergic neurons for parkinson\u2019s disease. Nature. 2025;641(8064):978\u201383.","journal-title":"Nature"},{"issue":"8064","key":"4660_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","volume":"641","author":"N Sawamoto","year":"2025","unstructured":"Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, Taruno Y, Shima A, Fushimi Y, Okada T, Kikuchi T, Morizane A, Hiramatsu S, Anazawa T, Shindo T, Ueno K, Morita S, Arakawa Y, Nakamoto Y, Miyamoto S, Takahashi R, Takahashi J. Phase I\/II trial of iPS-cell-derived dopaminergic cells for parkinson\u2019s disease. Nature. 2025;641(8064):971\u20137.","journal-title":"Nature"},{"issue":"7","key":"4660_CR35","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.tibtech.2025.02.009","volume":"43","author":"G Maisumu","year":"2025","unstructured":"Maisumu G, Willerth S, Nestor MW, Waldau B, Sch\u00fclke S, Nardi FV, Ahmed O, Zhou Y, Durens M, Liang B, Yakoub AM. Brain organoids: Building higher-order complexity and neural circuitry models. Trends Biotechnol. 2025;43(7):1583\u201398.","journal-title":"Trends Biotechnol"},{"issue":"8","key":"4660_CR36","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/thno.80271","volume":"13","author":"X Zheng","year":"2023","unstructured":"Zheng X, Han D, Liu W, Wang X, Pan N, Wang Y, Chen Z. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of parkinson\u2019s disease. Theranostics. 2023;13(8):2673\u201392.","journal-title":"Theranostics"},{"key":"4660_CR37","doi-asserted-by":"crossref","unstructured":"Fu C-L, Dong B-C, Jiang X, Li D, Yao J. A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a parkinson\u2019s disease mouse model. Heliyon 2024, 10, (2), e24234.","DOI":"10.1016\/j.heliyon.2024.e24234"},{"issue":"8054","key":"4660_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-024-08487-6","volume":"639","author":"SP Pa\u0219ca","year":"2025","unstructured":"Pa\u0219ca SP, Arlotta P, Bateup HS, Camp JG, Cappello S, Gage FH, Knoblich JA, Kriegstein AR, Lancaster MA, Ming G-L, Novarino G, Okano H, Parmar M, Park I-H, Reiner O, Song H, Studer L, Takahashi J, Temple S, Testa G, Treutlein B, Vaccarino FM, Vanderhaeghen P, Young-Pearse T. A framework for neural organoids, assembloids and transplantation studies. Nature. 2025;639(8054):315\u201320.","journal-title":"Nature"},{"issue":"2","key":"4660_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12015-021-10147-5","volume":"18","author":"D Hern\u00e1ndez","year":"2022","unstructured":"Hern\u00e1ndez D, Rooney LA, Daniszewski M, Gulluyan L, Liang HH, Cook AL, Hewitt AW, P\u00e9bay A. Culture variabilities of human iPSC-Derived cerebral organoids are a major issue for the modelling of phenotypes observed in alzheimer\u2019s disease. Stem Cell Reviews Rep. 2022;18(2):718\u201331.","journal-title":"Stem Cell Reviews Rep"},{"issue":"9","key":"4660_CR40","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.stemcr.2024.07.008","volume":"19","author":"MR Glass","year":"2024","unstructured":"Glass MR, Waxman EA, Yamashita S, Lafferty M, Beltran AA, Farah T, Patel NK, Singla R, Matoba N, Ahmed S, Srivastava M, Drake E, Davis LT, Yeturi M, Sun K, Love MI, Hashimoto-Torii K, French DL, Stein JL. Cross-site reproducibility of human cortical organoids reveals consistent cell type composition and architecture. Stem Cell Rep. 2024;19(9):1351\u201367.","journal-title":"Stem Cell Rep"},{"key":"4660_CR41","doi-asserted-by":"publisher","unstructured":"Kim TW, Piao J, Bocchi VD, Koo SY, Choi SJ, Chaudhry F, Yang D, Cho HS, Hergenreder E, Perera LR, Joshi S, Mrad ZA, Claros N, Donohue SA, Frank AK, Walsh R, Mosharov EV, Betel D, Tabar V, Studer L. Enhanced yield and subtype identity of hPSC-derived midbrain dopamine neuron by modulation of WNT and FGF18 signaling. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.01.06.631400.","DOI":"10.1101\/2025.01.06.631400"},{"key":"4660_CR42","doi-asserted-by":"crossref","unstructured":"Cai H, Tian C, Chen L, Yang Y, Sun AX, McCracken K, Tchieu J, Gu M, Mackie K, Guo F. Vascular network-inspired diffusible scaffolds for engineering functional midbrain organoids. Cell Stem Cell 2025.","DOI":"10.1101\/2024.08.31.610649"},{"issue":"7","key":"4660_CR43","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/glia.24167","volume":"70","author":"S Sabate-Soler","year":"2022","unstructured":"Sabate-Soler S, Nickels SL, Saraiva C, Berger E, Dubonyte U, Barmpa K, Lan YJ, Kouno T, Jarazo J, Robertson G, Sharif J, Koseki H, Thome C, Shin JW, Cowley SA, Schwamborn JC. Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality. Glia. 2022;70(7):1267\u201388.","journal-title":"Glia"},{"issue":"8","key":"4660_CR44","doi-asserted-by":"publisher","first-page":"dev166173","DOI":"10.1242\/dev.166173","volume":"146","author":"EM Holloway","year":"2019","unstructured":"Holloway EM, Capeling MM, Spence JR. Biologically inspired approaches to enhance human organoid complexity. Development. 2019;146(8):dev166173.","journal-title":"Development"},{"issue":"3","key":"4660_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.stem.2020.08.013","volume":"27","author":"A Bhaduri","year":"2020","unstructured":"Bhaduri A, Andrews MG, Kriegstein AR, Nowakowski TJ. Are organoids ready for prime time?? Cell Stem Cell. 2020;27(3):361\u20135.","journal-title":"Cell Stem Cell"},{"key":"4660_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ymeth.2021.07.008","volume":"203","author":"N-V Mohamed","year":"2022","unstructured":"Mohamed N-V, L\u00e9pine P, Lacalle-Aurioles M, Sirois J, Mathur M, Reintsch W, Beitel LK, Fon EA, Durcan TM. Microfabricated disk technology: rapid scale up in midbrain organoid generation. Methods. 2022;203:465\u201377.","journal-title":"Methods"},{"issue":"1","key":"4660_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s44319-023-00007-3","volume":"25","author":"A Lavazza","year":"2024","unstructured":"Lavazza A, Chinaia AA. Human brain organoids and their ethical issues. EMBO Rep. 2024;25(1):13\u20136.","journal-title":"EMBO Rep"},{"key":"4660_CR48","doi-asserted-by":"crossref","unstructured":"Hartung T, Morales Pantoja IE, Smirnova L. Brain organoids and organoid intelligence from ethical, legal, and social points of view. Front Artif Intell 2024, Volume 6\u20132023.","DOI":"10.3389\/frai.2023.1307613"},{"issue":"1","key":"4660_CR49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13287-020-1586-1","volume":"11","author":"J Vives","year":"2020","unstructured":"Vives J, Batlle-Morera L. The challenge of developing human 3D organoids into medicines. Stem Cell Res Ther. 2020;11(1):72.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4660_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41380-022-01892-1","volume":"28","author":"W Zhang","year":"2023","unstructured":"Zhang W, Jiang J, Xu Z, Yan H, Tang B, Liu C, Chen C, Meng Q. Microglia-containing human brain organoids for the study of brain development and pathology. Mol Psychiatry. 2023;28(1):96\u2013107.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4660_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41531-025-00882-8","volume":"11","author":"E Gerasimova","year":"2025","unstructured":"Gerasimova E, Beenen AC, Kachkin D, Regensburger M, Zundler S, Blumenthal DB, Lutzny-Geier G, Winner B, Prots I. Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in parkinson\u2019s disease. Npj Parkinson\u2019s Disease. 2025;11(1):36.","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"4660_CR52","doi-asserted-by":"publisher","first-page":"e52904","DOI":"10.7554\/eLife.52904","volume":"9","author":"H Renner","year":"2020","unstructured":"Renner H, Grabos M, Becker KJ, Kagermeier TE, Wu J, Otto M, Peischard S, Zeuschner D, TsyTsyura Y, Disse P, Klingauf J, Leidel SA, Seebohm G, Sch\u00f6ler HR, Bruder JM. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. eLife. 2020;9:e52904.","journal-title":"eLife"},{"issue":"12","key":"4660_CR53","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/mds.28775","volume":"36","author":"H Renner","year":"2021","unstructured":"Renner H, Sch\u00f6ler HR, Bruder JM. Combining automated organoid workflows with artificial Intelligence-Based analyses: opportunities to build a new generation of interdisciplinary High-Throughput screens for parkinson\u2019s disease and beyond. Mov Disord. 2021;36(12):2745\u201362.","journal-title":"Mov Disord"},{"issue":"12","key":"4660_CR54","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/s41592-023-02080-x","volume":"20","author":"D Reumann","year":"2023","unstructured":"Reumann D, Krauditsch C, Novatchkova M, Sozzi E, Wong SN, Zabolocki M, Priouret M, Doleschall B, Ritzau-Reid KI, Piber M, Morassut I, Fieseler C, Fiorenzano A, Stevens MM, Zimmer M, Bardy C, Parmar M, Knoblich JA. In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain\u2013striatum\u2013cortex assembloids. Nat Methods. 2023;20(12):2034\u201347.","journal-title":"Nat Methods"},{"issue":"20","key":"4660_CR55","doi-asserted-by":"publisher","first-page":"2409040","DOI":"10.1002\/advs.202409040","volume":"12","author":"G Gomez-Giro","year":"2025","unstructured":"Gomez-Giro G, Frangenberg D, Vega D, Zagare A, Barmpa K, Antony PMA, Robertson G, Sabahi-Kaviani R, Haendler K, Kruse N, Papastefanaki F, Matsas R, Spielmann M, Luttge R, Schwamborn JC. \u03b1-Synuclein pathology spreads in a Midbrain\u2013Hindbrain assembloid model. Adv Sci. 2025;12(20):2409040.","journal-title":"Adv Sci"},{"issue":"8","key":"4660_CR56","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.neuron.2025.02.010","volume":"113","author":"S-R Wu","year":"2025","unstructured":"Wu S-R, Nowakowski TJ. Exploring human brain development and disease using assembloids. Neuron. 2025;113(8):1133\u201350.","journal-title":"Neuron"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04660-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04660-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04660-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:04:05Z","timestamp":1758809045000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04660-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4660"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04660-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"502"}}